u/camila_mensa

the 503A/503B distinction is load-bearing, do not blur it

This is correct. Rodent data is investigational, not predictive.

Not convinced.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

You have restated the marketing copy. What is the actual substance here.

France here. Waited 20 months on an NHS list, gave up, went private, and the cost was half what I expected but the admin was worse.

This is correct. Rodent data is investigational, not predictive.

Right, and the corollary is that stopping escalation does not reset your tolerance, it just pauses the clock.

How long were you at 10mg before you moved up?

This result fits the template perfectly. Logged.

regulatory claims need a citation to the actual rule, not interpretation

glucagon-receptor contribution is appetite for dual and triple agonism

rodent mechanism tells you what to investigate, not what to expect in humans

This is the "correlation is mechanism" thing again. You changed three variables at once.

the sulphur burps passes. i promise. not medical advice.

Receptor distribution explains why the food-noise thing hits gastric emptying but not pharmacology.

special authorization is the cross-province difference

private plans vary by employer

incretin physiology is receptor, the mechanism layer

rodent receptor tells you what to investigate, not what to expect in humans

titration speed is Wegovy plus side effects, period